Ruggie Capital Group’s Labcorp LH Stock Holding History

Ruggie Capital Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-52	Closed	-$8K	–	195
2019 Q2	$8K	Buy	+52	New	+$7.26K	0.01%	130

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ruggie Capital Group's LH Position: Q3 2019 in Review

Ruggie Capital Group sold out of Labcorp (LH) in Q3 2019, closing a stake of 52 shares — an estimated $8K sold.

Ruggie Capital Group first reported a position in LH in Q2 2019 and held it in 1 quarter. The position peaked at $8K in Q2 2019. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

Ruggie Capital Group reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
Ruggie Capital Group sold 52 Labcorp shares in Q3 2019, an estimated $8K.
Ruggie Capital Group first reported a position in Labcorp in Q2 2019 and held it in 1 quarter.
Ruggie Capital Group's Labcorp position peaked at $8K in Q2 2019.
738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.